-
Brexpiprazole, sold
under the
brand name
Rexulti among others, is an
atypical antipsychotic medication used for the
treatment of
major depressive disorder...
- vilazodone. It is
similar to the
marketing strategy used for the drug
brexpiprazole,
labeling it as a "serotonin-dopamine
activity modulator" or 'SDAM'...
-
efficacy as
adjunctive agents; and, such
agents include:
Aripiprazole Brexpiprazole Cariprazine Olanzapine Quetiapine Ziprasidone whereas only quetiapine...
-
triggered by the
onset of agitation). On May 11, 2023, the FDA
approved brexpiprazole (brand name – Rexulti) as a
prescription medication for
treatment of...
- (Abilify) –
approved as an
adjunct to
antidepressant for
major depression Brexpiprazole (Rexulti) –
approved as an
adjunct to
antidepressant for
major depression...
- vortioxetine)
Atypical antipsychotics (e.g., aripiprazole, asenapine,
brexpiprazole, cariprazine, clozapine, lurasidone, quetiapine, ziprasidone) Azapirones...
- (U-66444B)
Aripiprazole (+sertraline)
Aripiprazole lauroxil Bifeprunox Brexpiprazole Brilaroxazine Cariprazine F-15063
Lumateperone Norclozapine Others:...
- focus.11.3.352. O'Connor,
Manjula (2020). "Adjunctive
therapy with
brexpiprazole improves treatment resistant complex post
traumatic stress disorder...
-
Benactyzine Benfluorex Benzydamine Benzoctamine Benzquinamide Biperiden Brexpiprazole Brivaracetam Bupropion Buspirone Butaperazine Butriptyline Cannabidiol...
-
Alfuzosin Anisodamine Anisodine Atiprosin Atypical antipsychotics (e.g.,
brexpiprazole, clozapine, olanzapine, quetiapine, risperidone)
Benoxathian Beta blockers...